The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


Oncolytics Biotech Inc up sharply

Oncolytics Biotech Inc closed up sharply Friday, rallying $0.01 or 1.69% to $0.60. Over the last five days, shares have gained 1.69% and 126.42% year to date. Shares have outperformed the S&P TSX by 23.93% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.13
Updated March 24 3:50 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense5334
Selling / general / administrative0000
Research & development3223
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total2111
Operating income-5-3-3-4
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Income before tax-5-3-3-4
Income after tax-5-3-3-4
Income tax, total0000
Net income-5-3-3-4
Total adjustments to net income--------
Net income before extra. items-5-3-3-4
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-5-3-3-4
Inc. avail. to common incl. extra. items-5-3-3-4
Diluted net income-5-3-3-4
Dilution adjustment--000
Diluted weighted average shares121121120118
Diluted EPS excluding extraordinary itemsvalue per share-0.04-0.03-0.02-0.03
Dividends per sharevalue per share0.
Diluted normalized EPSvalue per share-0.04-0.03-0.02-0.03